RxDoctor Payments Data

Christopher Straka, MD

Radiation Oncology · San Diego, CANPI 1801281399

Payments from drug & device makers

$7,203in general payments, 2019–2025

Across 208 payments — averaging $34.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GE HealthCare$2K
  • AstraZeneca$492
  • Merck$356
  • Johnson & Johnson$317
  • Novartis$277
  • Takeda Pharmaceuticals U.S.A., Inc.$251
  • plus $3K from 53 others

What the payments were for

  • Consulting fees$2,40033%
  • Food & beverage$4,72366%
  • Education$801%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GE HealthCare1$2,400
AstraZeneca(2 entities)21$492
Merck18$356
Johnson & Johnson15$317
Novartis13$277
Takeda Pharmaceuticals U.S.A., Inc.7$251
Daiichi Sankyo Inc.11$236
Regeneron Healthcare Solutions, Inc.8$233
Puma Biotechnology, Inc.7$175
Eisai Inc.7$173
Pharmaessentia USA Corporation5$169
Bayer8$151
Pfizer7$140
Blueprint Medicines Corporation6$140
Seagen Inc.3$93
Incyte Corporation4$80
Amgen3$74
Tersera Therapeutics LLC2$68
Foundation Medicine, Inc.4$63
Octapharma USA, Inc.3$61
Fresenius Kabi USA, LLC3$59
Rigel Pharmaceuticals, Inc.2$57
Beigene USA, Inc.2$57
Blue Earth Diagnostics2$56
ADC Therapeutics America, Inc.2$54
Sobi, Inc2$49
Sumitomo Pharma America, Inc.3$48
Coherus Oncology, Inc.2$48
Sun Pharmaceutical Industries Inc.2$46
Deciphera Pharmaceuticals Inc.2$42
Ipsen Biopharmaceuticals, Inc2$40
Servier Pharmaceuticals LLC2$40
Dendreon Pharmaceuticals LLC1$35
Tactile Systems Technology Inc2$34
Lilly USA, LLC2$34
Geron Corporation1$29
Verity Pharmaceuticals Inc.1$28
Astellas Pharma US Inc1$27
Pharmacyclics LLC, An Abbvie Company1$27
Menarini Silicon Biosystems, Inc.1$27
Tempus AI, Inc1$26
AbbVie1$26
Gilead1$26
EMD Serono, Inc.1$25
Sanofi1$24
Acceleron Pharma, Inc.1$24
Heron Therapeutics, Inc.1$23
Recordati_rare_diseases_inc.1$23
Pharmacosmos Therapeutics Inc.1$23
Taiho Oncology, Inc.1$22
Progenics Pharmaceuticals, Inc.1$22
Legend Biotech USA Inc.1$21
EUSA Pharma (US) LLC1$21
Accord Healthcare, Inc.1$20
Adaptive Biotechnologies Corporation1$20
Cardinal Health 414 LLC1$19
Jazz Pharmaceuticals Inc.1$18
Cumberland Pharmaceuticals, Inc.1$17
Novocure Inc.1$16

How this compares

$7,203 in reported general payments places this provider in the 80th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$519,430
Medicare patients
115
Services billed
1,894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mometasone Furoate60$1,431
Tamsulosin Hcl29$318

Paid to pharmacies, not to this prescriber.

Other radiation oncology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →